Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.

@article{Bonner2000SignificanceON,
  title={Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.},
  author={James A. Bonner and Jeffrey A Sloan and Kendrith M. Rowland and George G. Klee and John W. Kugler and James A. Mailliard and Martin Wiesenfeld and James E. Krook and Andrew W. Maksymiuk and Edward G. Shaw and Randolph S. Marks and Edith A. Perez},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2000},
  volume={6 2},
  pages={597-601}
}
The level of serum neuron-specific enolase (NSE) has been implicated as a prognostic factor for patients with small cell lung cancer (SCLC). A prospective evaluation was undertaken to assess the prognostic significance of pretreatment NSE and treatment-induced minimum NSE values in patients with SCLC. Patients from two Phase III North Central Cancer Treatment Group trials [one for patients with extensive stage SCLC and one for patients with limited stage SCLC] were asked to enter this… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Randomized double-blind placebocontrolled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study

  • K. M. Rowland, Jr., +13 authors J. R. Jett
  • J. Clin. Oncol.,
  • 1996
1 Excerpt

Similar Papers

Loading similar papers…